Shares of the brain-health specialist Sage Therapeutics (NASDAQ: SAGE) are having a tough trading session today. Specifically, the biotech's stock was down by approximately 13% on heavy volume as of 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results